Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:13:27 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:MCRB from 2023-05-04 to 2024-05-03 - 37 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-09 07:00U:MCRBNews ReleaseSeres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
2024-03-28 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-19 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-02-28 07:00U:MCRBNews ReleaseSeres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
2024-02-27 07:00U:MCRBNews ReleaseSeres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
2024-02-26 07:00U:MCRBNews ReleaseSeres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
2024-01-17 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-01-09 07:00U:MCRBNews ReleaseSeres Therapeutics Announces VOWST ¢ „ ¢ Commercial Launch Update and US FDA Fast Track Designation for SER-155
2024-01-04 16:00U:MCRBNews ReleaseSeres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-07 19:46U:MCRBNews ReleaseSeres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
2023-11-28 09:18U:MCRBNews ReleaseSeres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
2023-11-21 06:00U:MCRBNews ReleaseFlagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
2023-11-02 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST ¢ „ ¢ Net Sales of $7.6 Million
2023-11-01 10:30U:MCRBNews ReleaseFlagship Pioneering Launches Pioneering Intelligence
2023-10-30 17:30U:MCRBNews ReleaseSeres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST
2023-10-06 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-09-11 06:30U:MCRBNews ReleaseFlagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
2023-09-08 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-09-07 10:00U:MCRBNews ReleaseSeres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-29 09:00U:MCRBNews ReleaseInvaio achieves first registration for citrus greening solution featuring Trecise ¢ „ ¢ technology
2023-08-08 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
2023-08-04 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-08-01 07:00U:MCRBNews ReleaseSeres Therapeutics to Host Second Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on August 8, 2023
2023-08-01 07:00U:MCRBNews ReleaseSeres Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
2023-07-14 16:01U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-06-21 09:00U:MCRBNews ReleaseSeres Therapeutics Named to TIME100 Most Influential Companies List
2023-06-17 15:45U:MCRBNews ReleaseSeres Therapeutics and Nestl ƒ © Health Science Present Late-Breaking Data on VOWST ¢ „ ¢, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023
2023-06-09 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-06-09 07:00U:MCRBNews ReleaseSeres Therapeutics to Present at Goldman Sachs Global Healthcare Conference
2023-06-05 07:00U:MCRBNews ReleaseSeres Therapeutics and Nestl ƒ © Health Science Announce U.S. Commercial Availability of VOWST ¢ „ ¢, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection
2023-06-02 07:00U:MCRBNews ReleaseSeres Therapeutics to Present at Jefferies Healthcare Conference
2023-05-30 16:00U:MCRBNews ReleaseSeres Therapeutics Announces Receipt of $125 Million Milestone From Nestl ƒ © Health Science Following FDA Approval of VOWST ¢ „ ¢
2023-05-16 06:00U:MCRBNews ReleaseFlagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
2023-05-10 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-05-09 07:00U:MCRBNews ReleaseSeres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
2023-05-09 07:00U:MCRBNews ReleaseSeres Therapeutics Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination in the Gastrointestinal Microbiome
2023-05-05 07:00U:MCRBNews ReleaseSeres Therapeutics to Host First Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on May 9, 2023